Skip to main navigation
Skip to search
Skip to main content
Pure University (For Demo Only) Home
Help & FAQ
English
中文
Home
Profiles
Research units
Research output
Equipment
Datasets
Activities
Prizes
Impacts
Projects
Press/Media
Search by expertise, name or affiliation
Regression of melanoma following intravenous injection of plumbagin entrapped in transferrin-conjugated, lipid–polymer hybrid nanoparticles
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Regression of melanoma following intravenous injection of plumbagin entrapped in transferrin-conjugated, lipid–polymer hybrid nanoparticles'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anti-apoptosis
16%
Anticancer Nanomedicine
16%
Anticancer Properties
16%
Antiproliferative Activity
16%
B16F10
16%
B16F10 Melanoma
33%
Cancer Cell Lines
16%
Cancer Cells
16%
Cellular Uptake
16%
Hybrid Nanoparticles
100%
Intravenous Administration
16%
Intravenous Injection
100%
Melanocytic Tumor
16%
Melanoma
100%
Nanoparticle Formulation
16%
Naphthoquinone
16%
Plumbagin
100%
Systemic Injection
16%
Tail Vein Injection
16%
Therapeutic Concentrations
16%
Therapeutic Effect
16%
Therapeutic Efficacy
16%
Therapeutic Potential
16%
Transferrin
100%
Tumor
50%
Tumor Targeting
16%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
16%
Malignant Neoplasm
66%
Melanoma
100%
Mouse
33%
Nanomedicine
16%
Nanoparticle
100%
Naphthoquinone
16%
Neoplasm
83%
Officinal
16%
Plumbagin
100%
Therapeutic Effect
16%
Transferrin
100%